These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10981291)

  • 41. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
    Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
    Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chemotherapy for advanced non-small cell lung cancer].
    Ueoka H
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):770-6. PubMed ID: 15984514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New drugs for small-cell lung cancer.
    Murray N
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 9):38-42. PubMed ID: 9330407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Irinotecan in small-cell lung cancer: the US experience.
    Sandler AB
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):11-2. PubMed ID: 11221015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Ghezzi V; Frontini L; Giani L; Vaghi M; Ardizzoia A; Gardani GS
    Int J Biol Markers; 2004; 19(2):135-40. PubMed ID: 15255546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lung cancer: therapeutic options for stage IV and recurrent NSCLC.
    Calvo AR; Belani CP
    Cancer Treat Res; 2001; 105():189-227. PubMed ID: 11224988
    [No Abstract]   [Full Text] [Related]  

  • 48. New antineoplastic agents in lung cancer 1988-1993.
    Grant SC; Kris MG
    Cancer Treat Res; 1995; 72():323-47. PubMed ID: 7702990
    [No Abstract]   [Full Text] [Related]  

  • 49. In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
    Jensen PB; Holm B; Sorensen M; Christensen IJ; Sehested M
    Br J Cancer; 1997; 75(6):869-77. PubMed ID: 9062409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
    Saijo N
    Chest; 1998 Jan; 113(1 Suppl):17S-23S. PubMed ID: 9438685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Lung cancer].
    Furuse K
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1917-24. PubMed ID: 9350236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemoradiation in locally advanced non-small cell lung cancer.
    Bonomi P; Shirazi W
    Cancer Treat Res; 2001; 105():171-88. PubMed ID: 11224987
    [No Abstract]   [Full Text] [Related]  

  • 53. Combination chemotherapy with topotecan for non-small cell lung cancer.
    Dowlati A; Levitan N
    Lung Cancer; 2003 Aug; 41 Suppl 4():S23-6. PubMed ID: 14565511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial.
    Schiller JH; Kim K; Hutson P; DeVore R; Glick J; Stewart J; Johnson D
    J Clin Oncol; 1996 Aug; 14(8):2345-52. PubMed ID: 8708727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Irinotecan in small-cell lung cancer--Japanese trials.
    Fukuoka M; Masuda N; Kudoh S; Negoro S
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):57-62. PubMed ID: 10981292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [From ASCO and WCLC 2005 to clinical practice: "conventional" treatments].
    Fournel P
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S25-9. PubMed ID: 16719153
    [No Abstract]   [Full Text] [Related]  

  • 57. [New wave of chemotherapeutic agents: update in pulmonary oncology].
    Sculier JP
    Rev Mal Respir; 1997 Apr; 14(2):154-6. PubMed ID: 9198842
    [No Abstract]   [Full Text] [Related]  

  • 58. Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice.
    Kraus-Berthier L; Jan M; Guilbaud N; Naze M; Pierré A; Atassi G
    Clin Cancer Res; 2000 Jan; 6(1):297-304. PubMed ID: 10656461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer.
    Park SH; Cho EK; Kim Y; Kyung SY; An CH; Lee SP; Park JW; Jeong SH; Lee JI; Choi SJ; Park J; Shin DB; Lee JH
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1009-14. PubMed ID: 18259751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients.
    Comella P; Frasci G; Carnicelli P; Massidda B; Buzzi F; Filippelli G; Maiorino L; Guida M; Panza N; Mancarella S; Cioffi R
    Br J Cancer; 2004 Aug; 91(3):489-97. PubMed ID: 15266334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.